<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2026-170</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-10171</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДРУГИЕ ПРОБЛЕМЫ ЭНДОКРИНОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OTHER PROBLEMS OF ENDOCRINOLOGY</subject></subj-group></article-categories><title-group><article-title>Диагностическая ценность различных методов оценки кальциемии при первичном и вторичном гиперпаратиреозе</article-title><trans-title-group xml:lang="en"><trans-title>Diagnostic value of different methods for assessing calcemia in primary and secondary hyperparathyroidism</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-5416-5707</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Прошкина</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Proshkina</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Прошкина Анна Сергеевна, студент, факультет фундаментальной медицины</p><p>119991, Москва, Ленинские горы, д. 1</p></bio><bio xml:lang="en"><p>Anna S. Proshkina, Student, Faculty of Fundamental Medicine </p><p>1, Leninskie Gory, Moscow, 119991</p></bio><email xlink:type="simple">anyuta.proshkina@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2669-9457</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горбачева</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorbacheva</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Горбачева Анна Максимовна, к.м.н., врач-эндокринолог </p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Anna M. Gorbacheva, Cand. Sci. (Med.), Endocrinologist </p><p>11, Dmitry Ulyanov St., Moscow, 117036</p></bio><email xlink:type="simple">gorbacheva.anna@endocrincentr.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9462-8522</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Першина-Милютина</surname><given-names>A. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Pershina-Miliutina</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Першина-Милютина Анастасия Павловна, руководитель группы управления данными – врач-статистик </p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Anastasiia P. Pershina-Miliutina, Head of the Data Management Group – Statistician </p><p>11, Dmitry Ulyanov St., Moscow, 117036</p></bio><email xlink:type="simple">milyutina.anastasiya@endocrincentr.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-1336-4152</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аредов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Aredov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аредов Алексей Вячеславович, аналитик данных отдела цифровой трансформации </p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Aleksey V. Aredov, Data Analyst, Digital Transformation Department </p><p>11, Dmitry Ulyanov St., Moscow, 117036</p></bio><email xlink:type="simple">aredov.aleksey@endocrincentr.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6667-062X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Еремкина</surname><given-names>А. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Eremkina</surname><given-names>A. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Еремкина Анна Константиновна, к.м.н., заведующая отделением патологии околощитовидных желез и нарушений минерального обмена </p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Anna K. Eremkina, Cand. Sci. (Med.), Head of the Department of Pathology of Parathyroid Glands and Mineral Metabolism Disorders </p><p>11, Dmitry Ulyanov St., Moscow, 117036</p></bio><email xlink:type="simple">eremkina.anna@endocrincentr.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9717-9742</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мокрышева</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Mоkrysheva</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мокрышева Наталья Георгиевна, чл.корр. РАН, д.м.н., профессор, директор </p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Natalia G. Mokrysheva, Corr. Member RAS, Dr. Sci. (Med.), Professor, Director </p><p>11, Dmitry Ulyanov St., Moscow, 117036</p></bio><email xlink:type="simple">mokrisheva.natalia@endocrincentr.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Московский государственный университет имени М.В. Ломоносова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр эндокринологии имени академика И.И. Дедова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>25</day><month>06</month><year>2026</year></pub-date><volume>0</volume><issue>7</issue><fpage>84</fpage><lpage>92</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Прошкина А.С., Горбачева А.М., Першина-Милютина A.П., Аредов А.В., Еремкина А.К., Мокрышева Н.Г., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Прошкина А.С., Горбачева А.М., Першина-Милютина A.П., Аредов А.В., Еремкина А.К., Мокрышева Н.Г.</copyright-holder><copyright-holder xml:lang="en">Proshkina A.S., Gorbacheva A.M., Pershina-Miliutina A.P., Aredov A.V., Eremkina A.K., Mоkrysheva N.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/10171">https://www.med-sovet.pro/jour/article/view/10171</self-uri><abstract><sec><title>Введение</title><p>Введение. Дифференциальная диагностика первичного и вторичного гиперпаратиреоза имеет ключевое значение для выбора лечебной тактики. Постановка диагноза напрямую зависит от оценки кальциемии, для чего используют определение общего, ионизированного и альбумин-скорректированного кальция. Однако диагностическая ценность различных методов оценки кальциемии остается предметом дискуссий.</p></sec><sec><title>Цель</title><p>Цель. Сопоставить эффективность методов оценки кальциемии в дифференциальной диагностике первичного и вторичного гиперпаратиреоза.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В рамках исследования оценена диагностическая информативность различных методов определения кальция в сыворотке крови (общего; ионизированного, оцененного расчетным методом; скорректированного на уровень альбумина) с учетом их чувствительности, специфичности и прогностической значимости для постановки диагноза нормокальциемического варианта ПГПТ (нПГПТ) среди пациентов, госпитализированных в отделение патологии околощитовидных желез и нарушений минерального обмена ФГБУ «НМИЦ эндокринологии им. академика И.И. Дедова» Минздрава России в 2018–2024 гг. Дополнительно проведен анализ клинико-лабораторных характеристик нПГПТ по сравнению с пациентами с вторичным гиперпаратиреозом (ВГПТ). Для статистического анализа использовался пакет прикладных программ STATISTICA 12 StatSoft, Inc. Для анализа диагностической ценности исследуемых методов был выполнен ROC-анализ.</p></sec><sec><title>Результаты</title><p>Результаты. Частота нормокальциемического варианта первичного гиперпаратиреоза составила 6,7%. Существенных различий с вторичным гиперпаратиреозом по основным клинико-биохимическим показателям не выявлено. Наиболее информативными для диагностики оказались общий и альбумин-скорректированный кальций, тогда как ионизированный кальций, оцененный расчетным методом, показал меньшую ценность.</p></sec><sec><title>Выводы</title><p>Выводы. Для дифференциальной диагностики первичного и вторичного гиперпаратиреоза наибольшую ценность имеют показатели общего и альбумин-скорректированного кальция, которые могут рассматриваться как приоритетные методы оценки кальциемии в клинической практике.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Differential diagnosis of primary and secondary hyperparathyroidism is crucial for determining treatment tactics. Diagnosis directly depends on the assessment of calcemia, for which the determination of total, ionized, and albumin-adjusted calcium is used. However, the diagnostic value of various methods for assessing calcemia remains a subject of debate.</p></sec><sec><title>Aim</title><p>Aim. To compare the effectiveness of calcemia assessment methods in the differential diagnosis of primary and secondary hyperparathyroidism.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study evaluated the diagnostic informativeness of various methods for determining serum calcium (total; ionized, estimated by calculation; adjusted for albumin level), taking into account their sensitivity, specificity, and predictive value for diagnosing the normocalcemic variant of PHPT (nPHPT) among patients hospitalized at the Department of Parathyroid Pathology and Mineral Metabolism Disorders of the Federal State Budgetary Institution “National Medical Research Center for Endocrinology named after Academician I.I. Dedov” of the Ministry of Health of Russia from 2018 to 2024. An additional analysis of the clinical and laboratory characteristics of nPHPT compared to patients with secondary hyperparathyroidism (SHPT) was conducted. Statistical analysis was performed using the STATISTICA 12 software package (StatSoft, Inc.). ROC analysis was performed to analyze the diagnostic value of the studied methods.</p></sec><sec><title>Results</title><p>Results. The frequency of the normocalcemic variant of primary hyperparathyroidism was 6.7%. No significant differences from secondary hyperparathyroidism were found in the main clinical and biochemical parameters. Total and albuminadjusted calcium proved to be the most informative for diagnosis, while ionized calcium, estimated by calculation, showed less value.</p></sec><sec><title>Conclusions</title><p>Conclusions. For the differential diagnosis of primary and secondary hyperparathyroidism, total and albumin-adjusted calcium levels are of the greatest value and can be considered as priority methods for assessing calcemia in clinical practice.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гиперпаратиреоз</kwd><kwd>кальциемия</kwd><kwd>общий кальций</kwd><kwd>альбумин-скорректированный кальций</kwd><kwd>ионизированный кальций</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hyperparathyroidism</kwd><kwd>calcemia</kwd><kwd>total calcium</kwd><kwd>albumin-corrected calcium</kwd><kwd>ventilation function</kwd><kwd>dyspnea</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010;5(Suppl. 1):S23–S30. https://doi.org/10.2215/CJN.05910809.</mixed-citation><mixed-citation xml:lang="en">Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010;5(Suppl. 1):S23–S30. https://doi.org/10.2215/CJN.05910809.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Osterhoff G, Morgan EF, Shefelbine SJ, Karim L, McNamara LM, Augat P. Bone mechanical properties and changes with osteoporosis. Injury. 2010;5(Suppl. 1):S23–S30. https://doi.org/10.1016/S0020-1383(16)47003-8.</mixed-citation><mixed-citation xml:lang="en">Osterhoff G, Morgan EF, Shefelbine SJ, Karim L, McNamara LM, Augat P. Bone mechanical properties and changes with osteoporosis. Injury. 2010;5(Suppl. 1):S23–S30. https://doi.org/10.1016/S0020-1383(16)47003-8.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Brown EM. Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol Rev. 1991;71(2):371–411. https://doi.org/10.1152/physrev.1991.71.2.371.</mixed-citation><mixed-citation xml:lang="en">Brown EM. Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol Rev. 1991;71(2):371–411. https://doi.org/10.1152/physrev.1991.71.2.371.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Baird GS. Ionized calcium. Clin Chim Acta. 2011;412(9-10):696–701. https://doi.org/10.1016/j.cca.2011.01.004.</mixed-citation><mixed-citation xml:lang="en">Baird GS. Ionized calcium. Clin Chim Acta. 2011;412(9-10):696–701. https://doi.org/10.1016/j.cca.2011.01.004.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Flowers KC, Shipman KE, Shipman AR, Gittoes NJL. Investigative algorithms for disorders causing hypercalcaemia and hypocalcaemia: a narrative review. J Lab Prec Med. 2024;9:27. https://doi.org/10.21037/jlpm-24-6.</mixed-citation><mixed-citation xml:lang="en">Flowers KC, Shipman KE, Shipman AR, Gittoes NJL. Investigative algorithms for disorders causing hypercalcaemia and hypocalcaemia: a narrative review. J Lab Prec Med. 2024;9:27. https://doi.org/10.21037/jlpm-24-6.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wang S, McDonnell EH, Sedor FA, Toffaletti JG. pH effects on measurements of ionized calcium and ionized magnesium in blood. Arch Pathol Lab Med. 2002;126(8):947–950. https://doi.org/10.5858/2002-126-0947-PEOMOI.</mixed-citation><mixed-citation xml:lang="en">Wang S, McDonnell EH, Sedor FA, Toffaletti JG. pH effects on measurements of ionized calcium and ionized magnesium in blood. Arch Pathol Lab Med. 2002;126(8):947–950. https://doi.org/10.5858/2002-126-0947-PEOMOI.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng HP, Wei S, Wei LP, Verkhratsky A. Calcium signaling in physiology and pathophysiology. Acta Pharmacol Sin. 2006;27(7):767–772. https://doi.org/10.1111/j.1745-7254.2006.00399.x.</mixed-citation><mixed-citation xml:lang="en">Cheng HP, Wei S, Wei LP, Verkhratsky A. Calcium signaling in physiology and pathophysiology. Acta Pharmacol Sin. 2006;27(7):767–772. https://doi.org/10.1111/j.1745-7254.2006.00399.x.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Goltzman D, Mannstadt M, Marcocci C. Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis. In: Giustina A, Bilezikian JP (eds.). Vitamin D in Clinical Medicine. Basel, S.Karger AG; 2018, vol. 50, pp. 1–15. https://doi.org/10.1159/000486060.</mixed-citation><mixed-citation xml:lang="en">Goltzman D, Mannstadt M, Marcocci C. Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis. In: GiustinaA, Bilezikian JP (eds.). Vitamin D in Clinical Medicine. Basel, S.Karger AG; 2018, vol. 50, pp. 1–15. https://doi.org/10.1159/000486060.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cusano NE, Cetani F. Normocalcemic primary hyperparathyroidism. Arch Endocrinol Metab. 2022;66(5):666–677. https://doi.org/10.20945/2359-3997000000556.</mixed-citation><mixed-citation xml:lang="en">Cusano NE, Cetani F. Normocalcemic primary hyperparathyroidism. Arch Endocrinol Metab. 2022;66(5):666–677. https://doi.org/10.20945/2359-3997000000556.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Баранова ИА, Зыкова ТА. Нормокальциемический первичный гиперпаратиреоз – «новая эра» в диагностике старого заболевания. Проблемы эндокринологии. 2017;63(4):236–244. https://doi.org/10.14341/probl2017634236-244.</mixed-citation><mixed-citation xml:lang="en">Baranova IA, Zykova TA. Normocalcemic primary hyperparathyroidism – "new era" in diagnosis of an old disease. Problemy Endokrinologii. 2017;63(4): 236–244. (In Russ.) https://doi.org/10.14341/probl2017634236-244.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mokrysheva NG, Eremkina AK, Elfimova AR, Kovaleva EV, Miliutina AP, Bibik EE et al. The Russian registry of primary hyperparathyroidism, latest update. Front Endocrinol. 2023;14:1203437. https://doi.org/10.3389/fendo.2023.1203437.</mixed-citation><mixed-citation xml:lang="en">Mokrysheva NG, Eremkina AK, Elfimova AR, Kovaleva EV, Miliutina AP, Bibik EE et al. The Russian registry of primary hyperparathyroidism, latest update. Front Endocrinol. 2023;14:1203437. https://doi.org/10.3389/fendo.2023.1203437.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Vashist SK. Point-of-Care Diagnostics: Recent Advances and Trends. Biosensors. 2017;7(4):62. https://doi.org/10.3390/bios7040062.</mixed-citation><mixed-citation xml:lang="en">Vashist SK. Point-of-Care Diagnostics: Recent Advances and Trends. Biosensors. 2017;7(4):62. https://doi.org/10.3390/bios7040062.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lyu Y, Gan S, Bao Y, Zhong L, Xu J, Wang W et al. Solid-Contact Ion-Selective Electrodes: Response Mechanisms, Transducer Materials and Wearable Sensors. Membranes. 2020;10(6):128.https://doi.org/10.3390/membranes10060128.</mixed-citation><mixed-citation xml:lang="en">Lyu Y, Gan S, Bao Y, Zhong L, Xu J, Wang W et al. Solid-Contact Ion-Selective Electrodes: Response Mechanisms, Transducer Materials and Wearable Sensors. Membranes. 2020;10(6):128.https://doi.org/10.3390/membranes10060128.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Boink AB, Buckley BM, Christiansen TF, Covington AK, Maas AH, Muller-Plathe O et al. IFCC recommendation on sampling, transport and storage for the determination of the concentration of ionized calcium in whole blood, plasma and serum. J Automat Chem. 1991;13(5):235–239. https://doi.org/10.1155/S1463924691000391.</mixed-citation><mixed-citation xml:lang="en">Boink AB, Buckley BM, Christiansen TF, Covington AK, Maas AH, MullerPlathe O et al. IFCC recommendation on sampling, transport and storage for the determination of the concentration of ionized calcium in whole blood, plasma and serum. J Automat Chem. 1991;13(5):235–239. https://doi.org/10.1155/S1463924691000391.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Grzych G, Roland E, Beauvais D, Maboudou P, Lippi G. Leukocytosis interference in clinical chemistry: Shall we still interpret test results without hematological data? J Med Biochem. 2020;39(1):66–71. https://doi.org/10.2478/jomb-2019-0005.</mixed-citation><mixed-citation xml:lang="en">Grzych G, Roland E, Beauvais D, Maboudou P, Lippi G. Leukocytosis interference in clinical chemistry: Shall we still interpret test results without hematological data? J Med Biochem. 2020;39(1):66–71. https://doi.org/10.2478/jomb-2019-0005.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Toffaletti J, Blosser N, Kirvan K. Effects of storage temperature and time before centrifugation on ionized calcium in blood collected in plain vacutainer tubes and silicone-separator (SST) tubes. Clin Chem. 1984;30(4):553–556. https://doi.org/10.1093/clinchem/30.4.553.</mixed-citation><mixed-citation xml:lang="en">Toffaletti J, Blosser N, Kirvan K. Effects of storage temperature and time before centrifugation on ionized calcium in blood collected in plain vacutainer tubes and silicone-separator (SST) tubes. Clin Chem. 1984;30(4):553–556. https://doi.org/10.1093/clinchem/30.4.553.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Haverstick DM, Brill LB, 2nd, Scott MG, Bruns DE. Preanalytical variables in measurement of free (ionized) calcium in lithium heparin-containing blood collection tubes. Clin Chim Acta. 2009;403(1-2):102–104. https://doi.org/10.1016/j.cca.2009.01.026.</mixed-citation><mixed-citation xml:lang="en">Haverstick DM, Brill LB, 2nd, Scott MG, Bruns DE. Preanalytical variables in measurement of free (ionized) calcium in lithium heparin-containing blood collection tubes. Clin Chim Acta. 2009;403(1-2):102–104. https://doi.org/10.1016/j.cca.2009.01.026.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kallner A. Preanalytical procedures in the measurement of ionized calcium in serum and plasma. Eur J Clin Chem Clin Biochem. 1996;34(1):53–58. https://doi.org/10.1515/cclm.1996.34.1.53.</mixed-citation><mixed-citation xml:lang="en">Kallner A. Preanalytical procedures in the measurement of ionized calcium in serum and plasma. Eur J Clin Chem Clin Biochem. 1996;34(1):53–58. https://doi.org/10.1515/cclm.1996.34.1.53.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Barth JH, Fiddy JB, Payne RB. Adjustment of serum total calcium for albumin concentration: effects of non-linearity and of regression differences between laboratories. Ann Clin Biochem. 1996;33(1):55–58. https://doi.org/10.1177/000456329603300108.</mixed-citation><mixed-citation xml:lang="en">Barth JH, Fiddy JB, Payne RB. Adjustment of serum total calcium for albumin concentration: effects of non-linearity and of regression differences between laboratories. Ann Clin Biochem. 1996;33(1):55–58. https://doi.org/ 10.1177/000456329603300108.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Phillips P, Pain R. Correcting the calcium. Br Med J. 1977;1(6074):1473. https://doi.org/10.1136/bmj.1.6074.1473-a.</mixed-citation><mixed-citation xml:lang="en">Phillips P, Pain R. Correcting the calcium. Br Med J. 1977;1(6074):1473. https://doi.org/10.1136/bmj.1.6074.1473-a.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Tee MC, Holmes DT, Wiseman SM. Ionized vs serum calcium in the diagnosis and management of primary hyperparathyroidism: which is superior? Am J Surg. 2013;205(5):591–596; d https://doi.org/10.1016/j.amjsurg.2013.01.017.</mixed-citation><mixed-citation xml:lang="en">Tee MC, Holmes DT, Wiseman SM. Ionized vs serum calcium in the diagnosis and management of primary hyperparathyroidism: which is superior? Am J Surg. 2013;205(5):591–596; d https://doi.org/10.1016/j.amjsurg.2013.01.017.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ridefelt P, Helmersson-Karlqvist J. Albumin adjustment of total calcium does not improve the estimation of calcium status. Scand J Clin Lab Invest. 2017;77(6):442–447. https://doi.org/10.1080/00365513.2017.1336568.</mixed-citation><mixed-citation xml:lang="en">Ridefelt P, Helmersson-Karlqvist J. Albumin adjustment of total calcium does not improve the estimation of calcium status. Scand J Clin Lab Invest. 2017;77(6):442–447. https://doi.org/10.1080/00365513.2017.1336568.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Alhenc-Gelas M, Lefevre G, Bachmeyer C, M'Bappe P, Ouahabi S, Grateau G et al. Poor performance of albumin or protein-adjusted plasma calcium to diagnose dyscalcemia in hospitalized patients: A confirmatory study in a general internal medicine department. Rev Med Interne. 2022;43(4):206–211. https://doi.org/10.1016/j.revmed.2021.11.006.</mixed-citation><mixed-citation xml:lang="en">Alhenc-Gelas M, Lefevre G, Bachmeyer C, M'Bappe P, Ouahabi S, Grateau G et al. Poor performance of albumin or protein-adjusted plasma calcium to diagnose dyscalcemia in hospitalized patients: A confirmatory study in a general internal medicine department. Rev Med Interne. 2022;43(4):206–211. https://doi.org/10.1016/j.revmed.2021.11.006.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Pawade YR, Ghangale SS, Dahake HS. Albumin-adjusted calcium: Are previously published regression equations reliable for your laboratory? – A pilot study. Int J Med Sci Public Health. 2013;2(2):217–222. https://doi.org/10.5455/ijmsph.2013.2.209-214.</mixed-citation><mixed-citation xml:lang="en">Pawade YR, Ghangale SS, Dahake HS. Albumin-adjusted calcium: Are previously published regression equations reliable for your laboratory? – A pilot study. Int J Med Sci Public Health. 2013;2(2):217–222. https://doi.org/10.5455/ijmsph.2013.2.209-214.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов ИИ, Мельниченко ГА, Мокрышева НГ, Андреева ЕН, Анциферов МБ, Бельцевич ДГ и др. Проект клинических рекомендаций по диагностике и лечению первичного гиперпаратиреоза у взрослых пациентов. Эндокринная хирургия. 2023;16(4):5–54. https://doi.org/10.14341/serg12790.</mixed-citation><mixed-citation xml:lang="en">Dedov II, Melnichenko GA, Mokrysheva NG, Andreeva EN, Antsiferov MB, Beltsevich DG et al. Draft of clinical guidelines for the diagnosis and treatment of primary hyperparathyroidism in adult patients. Endocrine Surgery. 2022;16(4):5–54. (In Russ.) https://doi.org/10.14341/serg12790.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S et al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res. 2022;37(11):2293–2314. https://doi.org/10.1002/jbmr.4677.</mixed-citation><mixed-citation xml:lang="en">Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S et al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res. 2022;37(11):2293–2314. https://doi.org/10.1002/jbmr.4677.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Мамедова ЕО, Голоунина ОО, Белая ЖЕ. Коррекция общего кальция в крови на альбумин: есть ли целесообразность? Проблемы эндокринологии. 2024;70(6):45–61. https://doi.org/10.14341/probl13503.</mixed-citation><mixed-citation xml:lang="en">Mamedova EO, Golounina OO, Belaya ZE. Albumin adjustment of total serum calcium – is it worth doing? Problemy Endokrinologii. 2024;70(6):45–61. (In Russ.) https://doi.org/10.14341/probl13503.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Kabadi UM. Low 25-Hydroxyvitamin D in Primary Hyperparathyroidism: Enhanced Conversion Into 1,25-Hydroxyvitamin D May Not Be "True" Deficiency. JBMR Plus. 2020;4(11):e10415. https://doi.org/10.1002/jbm4.10415.</mixed-citation><mixed-citation xml:lang="en">Kabadi UM. Low 25-Hydroxyvitamin D in Primary Hyperparathyroidism: Enhanced Conversion Into 1,25-Hydroxyvitamin D May Not Be "True" Deficiency. JBMR Plus. 2020;4(11):e10415. https://doi.org/10.1002/jbm4.10415.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Meng L, Su C, Shapses SA, Wang X. Total and free vitamin D metabolites in patients with primary hyperparathyroidism. J Endocrinol Invest. 2022;45(2):301–307. https://doi.org/10.1007/s40618-021-01633-1.</mixed-citation><mixed-citation xml:lang="en">Meng L, Su C, Shapses SA, Wang X. Total and free vitamin D metabolites in patients with primary hyperparathyroidism. J Endocrinol Invest. 2022;45(2):301–307. https://doi.org/10.1007/s40618-021-01633-1.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Clements MR, Davies M, Fraser DR, Lumb GA, Mawer EB, Adams PH. Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci. 1987;73(6):659–664. https://doi.org/10.1042/cs0730659.</mixed-citation><mixed-citation xml:lang="en">Clements MR, Davies M, Fraser DR, Lumb GA, Mawer EB, Adams PH. Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci. 1987;73(6):659–664. https://doi.org/10.1042/cs0730659.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Walker MD, Bilezikian JP. Vitamin D and primary hyperparathyroidism: more insights into a complex relationship. Endocrine. 2017;55(1):3–5. https://doi.org/10.1007/s12020-016-1169-1.</mixed-citation><mixed-citation xml:lang="en">Walker MD, Bilezikian JP. Vitamin D and primary hyperparathyroidism: more insights into a complex relationship. Endocrine. 2017;55(1):3–5. https://doi.org/10.1007/s12020-016-1169-1.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X, Sheng Z, Meng L, Su C, Trooskin S, Shapses SA. 25-Hydroxyvitamin D and Vitamin D Binding Protein Levels in Patients With Primary Hyperparathyroidism Before and After Parathyroidectomy. Front Endocrinol. 2019;10:171. https://doi.org/10.3389/fendo.2019.00171.</mixed-citation><mixed-citation xml:lang="en">Wang X, Sheng Z, Meng L, Su C, Trooskin S, Shapses SA. 25-Hydroxyvitamin D and Vitamin D Binding Protein Levels in Patients With Primary Hyperparathyroidism Before and After Parathyroidectomy. Front Endocrinol. 2019;10:171. https://doi.org/10.3389/fendo.2019.00171.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Desgagnes N, King JA, Kline GA, Seiden-Long I, Leung AA. Use of Albumin-Adjusted Calcium Measurements in Clinical Practice. JAMA Netw Open. 2025;8(1):e2455251. https://doi.org/10.1001/jamanetworkopen.2024.55251.</mixed-citation><mixed-citation xml:lang="en">Desgagnes N, King JA, Kline GA, Seiden-Long I, Leung AA. Use of AlbuminAdjusted Calcium Measurements in Clinical Practice. JAMA Netw Open. 2025;8(1):e2455251. https://doi.org/10.1001/jamanetworkopen.2024.55251.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Nordenstrom E, Katzman P, Bergenfelz A. Biochemical diagnosis of primary hyperparathyroidism: Analysis of the sensitivity of total and ionized calcium in combination with PTH. Clin Biochem. 2011;44(10-11):849–852. https://doi.org/10.1016/j.clinbiochem.2011.04.002.</mixed-citation><mixed-citation xml:lang="en">Nordenstrom E, Katzman P, Bergenfelz A. Biochemical diagnosis of primary hyperparathyroidism: Analysis of the sensitivity of total and ionized calcium in combination with PTH. Clin Biochem. 2011;44(10-11):849–852. https://doi.org/10.1016/j.clinbiochem.2011.04.002.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Pekar JD, Grzych G, Durand G, Haas J, Lionet A, Brousseau T et al. Calcium state estimation by total calcium: the evidence to end the never-ending story. Clin Chem Lab Med. 2020;58(2):222–231. https://doi.org/10.1515/cclm-2019-0568.</mixed-citation><mixed-citation xml:lang="en">Pekar JD, Grzych G, Durand G, Haas J, Lionet A, Brousseau T et al. Calcium state estimation by total calcium: the evidence to end the never-ending story. Clin Chem Lab Med. 2020;58(2):222–231. https://doi.org/10.1515/cclm-2019-0568.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Ong GS, Walsh JP, Stuckey BG, Brown SJ, Rossi E, Ng JL et al. The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism. J Clin Endocrinol Metab. 2012;97(9):3138–3145. https://doi.org/10.1210/jc.2012-1429.</mixed-citation><mixed-citation xml:lang="en">Ong GS, Walsh JP, Stuckey BG, Brown SJ, Rossi E, Ng JL et al. The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism. J Clin Endocrinol Metab. 2012;97(9):3138–3145. https://doi.org/10.1210/jc.2012-1429.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
